Results 101 to 110 of about 1,182,342 (316)
Determining Parental Factors for Clinical Trial Attrition in Pediatric Acute Lymphoblastic Leukemia
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background/Objectives Despite high enrollment rates on Children's Oncology Group (COG) protocols, attrition after initial consent is challenging, introducing bias and prolonging trial completion. While adult oncology literature has identified predictors of withdrawal, little is known about caregiver decision‐making for child participation in ...
Kimberly L. Stathas +3 more
wiley +1 more source
Rapid two-step purification of a recombinant mouse Fab fragment expressed in Escherichia coli [PDF]
, 2001 We report a rapid, large-scale process for the purification of a recombinant Fab fragment specific for the tobacco mosaic virus coat protein (Fab57P). The fragment is expressed periplasmically in Escherichia coli.
Wlad, H, +4 more
core
Risk Management and Healthcare PolicyPan Wang,1,* Jun-Nan Xiao,1,* Yan-Yu Liu,2 Long Xiao,1 Jie-Li Chen,1 Yu Wang,1 Li-Hua Yang,3 Xiu-Li Feng4 1Blood Purification Centre, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510000, People’s Republic of ...
Wang P +7 more
doaj
A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho +7 more
wiley +1 more source
Genetic immunization for the recovery and purification of recombinant proteins [PDF]
, 2000 A system that uses genetic immunization for recombinant protein recovery and purification is described. The genetic sequence encoding a target protein is sub-cloned into both a eukaryotic and a prokaryotic vector.
Albani S., La Cava A.
core +1 more source
International Journal of General MedicineChangjing Shi,1,* Juan Wang,2,* Weichen Liu,2 Yiyi Mo,2 Yuan Huang,2 Xiaoxiao Wei,2 Dongmei Huo,2,* Aifang Huang2,* 1Information Technology Center, The First Affiliated Hospital of Guangxi Medical University, Nanning ...
Shi C +7 more
doaj
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi +9 more
wiley +1 more source
The effect of the erythropoietin resistance index on brain hemorrhage and infarction risk in maintenance hemodialysis patients: a retrospective cohort study [PDF]
PeerJBackground Maintenance hemodialysis (MHD) is the main renal replacement therapy for patients with end-stage renal disease, and erythropoietin (EPO) is the main therapy for renal anemia in patients receiving maintenance hemodialysis. However, the risks of
Mingyu Liu +6 more
doaj +2 more sources
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola +4 more
wiley +1 more source
Renal FailureBackground Elderly hemodialysis (HD) patients have a high risk of death. The effect of different types of HD membranes on survival is still controversial.
Wanqing Huang +9 more
doaj +1 more source